Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ambrogio Orlando

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|January 12, 2022
Ozanimod for Ulcerative ColitisFabio S Macaluso, Ambrogio Orlando
Alimentary Pharmacology & Therapeutics|May 10, 2023
Editorial: adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease-time for universal recommendation?Fabio Salvatore Macaluso, Ambrogio Orlando
Gastroenterology|May 15, 2020
Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?Fabio Salvatore Macaluso, Ambrogio Orlando
Alimentary Pharmacology & Therapeutics|December 28, 2020
Letter: propensity score-handle with careFabio Salvatore Macaluso, Ambrogio Orlando
Med (New York, N.Y.)|March 15, 2025
Guselkumab in moderately to severely active ulcerative colitis: Another interleukin-23p19 subunit inhibitor or more?Ambrogio Orlando, Fabio Salvatore Macaluso
Minerva Gastroenterologica E Dietologica|October 12, 2019
Anti-TNF combination therapy in inflammatory bowel disease: de novo or selective?Fabio S Macaluso, Ambrogio Orlando
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 15, 2020
COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical dataFabio Salvatore Macaluso, Ambrogio Orlando
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 8, 2022
Epidemiological trends in pediatric inflammatory bowel disease: The precious contribution of the registries promoted by scientific societiesAmbrogio Orlando, Fabio Salvatore Macaluso
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 26, 2023
Author's reply: "Tofacitinib in ulcerative colitis-Small molecule but large effect"Fabio Salvatore Macaluso, Ambrogio Orlando
Expert Opinion on Investigational Drugs|September 15, 2010
Investigational agents for Crohn's diseaseMario Cottone, Ambrogio Orlando, Sara Renna
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|January 12, 2022
Ozanimod for Ulcerative ColitisFabio S Macaluso, Ambrogio Orlando
Alimentary Pharmacology & Therapeutics|May 10, 2023
Editorial: adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease-time for universal recommendation?Fabio Salvatore Macaluso, Ambrogio Orlando
Gastroenterology|May 15, 2020
Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?Fabio Salvatore Macaluso, Ambrogio Orlando
Alimentary Pharmacology & Therapeutics|December 28, 2020
Letter: propensity score-handle with careFabio Salvatore Macaluso, Ambrogio Orlando
Med (New York, N.Y.)|March 15, 2025
Guselkumab in moderately to severely active ulcerative colitis: Another interleukin-23p19 subunit inhibitor or more?Ambrogio Orlando, Fabio Salvatore Macaluso
Minerva Gastroenterologica E Dietologica|October 12, 2019
Anti-TNF combination therapy in inflammatory bowel disease: de novo or selective?Fabio S Macaluso, Ambrogio Orlando
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 15, 2020
COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical dataFabio Salvatore Macaluso, Ambrogio Orlando
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 8, 2022
Epidemiological trends in pediatric inflammatory bowel disease: The precious contribution of the registries promoted by scientific societiesAmbrogio Orlando, Fabio Salvatore Macaluso
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 26, 2023
Author's reply: "Tofacitinib in ulcerative colitis-Small molecule but large effect"Fabio Salvatore Macaluso, Ambrogio Orlando
Expert Opinion on Investigational Drugs|September 15, 2010
Investigational agents for Crohn's diseaseMario Cottone, Ambrogio Orlando, Sara Renna
Pageof 22